Inflammaging: How Chronic Low-Grade Inflammation Quietly Accelerates Your Aging

What Is Inflammaging: Franceschi's Framework for Inflammatory Aging

The concept of inflammaging emerged from a landmark 2000 paper by Claudio Franceschi and colleagues in the Annals of the New York Academy of Sciences. Franceschi observed something paradoxical in long-lived individuals: their immune systems showed hallmarks of chronic activation yet they remained relatively protected from the diseases this activation typically causes. The term he coined — a portmanteau of "inflammation" and "aging" — described not a disease state but a physiological trajectory that all humans follow as they age.

Sterile vs. Infectious Inflammation: Why Inflammaging Is Different

Classical inflammation is a protective response to pathogens, injury, or tissue damage. It activates rapidly, eliminates the threat, and resolves. Inflammaging is fundamentally different: it is sterile — triggered without infection — chronic — persisting indefinitely — and low-grade — below the threshold detectable by standard clinical markers. Standard CRP tests flag inflammation above 10 mg/L; inflammaging operates at 0.5–3 mg/L, chronically, for decades.

This distinction matters clinically. Standard blood panels don't catch inflammaging until it has already driven significant tissue damage. High-sensitivity CRP (hs-CRP) and direct IL-6 measurement are required to detect the signal early.

Acute vs. Chronic: The Hormetic Divide

Acute inflammation is hormetic — a brief, intense signal that drives adaptation and repair. Exercise, intermittent fasting, and heat stress all trigger acute inflammatory bursts that resolve and leave tissues stronger. Chronic low-grade inflammation, by contrast, operates below adaptive thresholds while continuously degrading tissue homeostasis. It activates the NF-κB pathway persistently, rather than in controlled pulses.

The NLRP3 Inflammasome: Molecular Trigger of Sterile Inflammation

The NLRP3 inflammasome is a multiprotein complex that acts as a molecular sensor for cellular danger signals. When activated by uric acid crystals, cholesterol crystals, saturated fatty acids, ATP released from damaged cells, or mitochondrial DNA, NLRP3 triggers caspase-1, which cleaves IL-1β and IL-18 into their active pro-inflammatory forms. NLRP3 activation increases with age and is considered a primary driver of the sterile inflammatory state underlying inflammaging. Drugs targeting NLRP3 (MCC950, colchicine analogs) are among the most promising anti-aging therapeutics in current trials.

Key Inflammaging Biomarkers: What to Measure and What Ranges Mean

Inflammaging is a measurable, quantifiable phenomenon. The challenge is that standard clinical panels are designed to detect acute illness, not chronic low-grade inflammation. You need specific tests ordered at the right sensitivity to characterize your inflammatory status accurately.

IL-6: The Primary Longevity Predictor

Interleukin-6 is the biomarker most consistently associated with mortality, disability, and cognitive decline in aging research. The landmark InCHIANTI study (Ferrucci et al., 2005) followed 1,020 adults over age 65 and found that individuals in the highest IL-6 quartile had a 2.1× higher all-cause mortality risk over 6 years, independent of disease status. IL-6 rises approximately 2-fold per decade after age 50 in otherwise healthy individuals — this trajectory alone predicts biological age more accurately than chronological age in several longevity cohorts.

IL-6 is both a pro-inflammatory cytokine and a pleiotropic hormone. In skeletal muscle during exercise (as "myokine"), it has beneficial effects. In adipose tissue, liver, and brain at elevated baseline levels, it drives insulin resistance, amyloid production, and cardiovascular remodeling. The context and duration of elevation are everything.

CRP and hs-CRP: The Accessible Surrogate

C-reactive protein is produced by the liver in response to IL-6 signaling, making it a useful indirect measure of IL-6 activity. Standard CRP (detecting above 10 mg/L) misses inflammaging entirely. High-sensitivity CRP (hs-CRP) detects down to 0.1 mg/L and is the appropriate test for cardiovascular risk stratification and inflammaging monitoring. The JUPITER trial demonstrated that hs-CRP above 2 mg/L in individuals with LDL below 130 mg/dL still predicted significant cardiovascular event risk, validating it as an independent marker.

TNF-α: The Tissue Remodeling Cytokine

Tumor necrosis factor-alpha activates NF-κB directly, promotes insulin resistance by interfering with IRS-1 signaling, and drives sarcopenia by suppressing muscle protein synthesis. TNF-α rises with age, adipose tissue accumulation, and CMV burden. It is produced in large quantities by the SASP of senescent cells. Soluble TNF-α receptor levels (sTNFR1, sTNFR2) are sometimes more stable measurements than TNF-α itself.

IL-1β: The NLRP3 Output

IL-1β is the direct output of NLRP3 inflammasome activation. It drives fever, acute phase responses, and in chronic settings promotes atherosclerotic plaque instability, gout, and neuroinflammation. The CANTOS trial (Ridker et al., 2017) demonstrated that canakinumab — a monoclonal antibody targeting IL-1β — reduced cardiovascular events by 15% independent of lipid lowering, providing proof-of-concept that IL-1β-mediated inflammation is a causal driver of cardiovascular aging.

Fibrinogen: The Coagulation-Inflammation Link

Fibrinogen is an acute phase reactant that rises with systemic inflammation and independently predicts cardiovascular events, stroke, and all-cause mortality. Elevated fibrinogen reflects sustained hepatic inflammatory signaling and contributes mechanistically to thrombotic risk. Target levels are below 350 mg/dL; above 450 mg/dL represents significant elevated risk.

Sources of Chronic Inflammation: The Five Drivers of Inflammaging

Inflammaging does not have a single cause. It emerges from a convergence of five major inflammatory input streams, each amplifying the others through shared downstream signaling. Understanding these sources is essential for targeted intervention.

Senescent Cell SASP: The Cellular Waste Problem

Cellular senescence is a state where cells permanently exit the cell cycle after experiencing DNA damage, telomere shortening, or oncogenic stress. Senescent cells do not die — they persist and secrete a chronic, tissue-remodeling cocktail called the Senescence-Associated Secretory Phenotype (SASP). The SASP includes IL-6, IL-8, TNF-α, MMP-3, MMP-9, PAI-1, and dozens of other cytokines, chemokines, and proteases. James Kirkland's work at Mayo Clinic has shown that even a small number of senescent cells (as few as 1 in 10,000) transplanted into young mice accelerates all hallmarks of aging. Conversely, eliminating senescent cells with senolytics (dasatinib + quercetin) extends healthspan in multiple mouse models.

Senescent cell burden accumulates with age, irradiation, chemotherapy, chronic stress, and metabolic disease. By age 70, measurable SASP-positive cells are detectable in most tissues.

Gut Permeability and LPS Translocation

The gut microbiome produces lipopolysaccharide (LPS) — a potent inflammatory endotoxin — as a natural byproduct of gram-negative bacterial cell wall turnover. In a healthy gut, the intestinal epithelial barrier prevents LPS from entering systemic circulation. With age, gut permeability increases — a phenomenon sometimes called "leaky gut" — allowing low levels of LPS to translocate across the intestinal barrier and into the bloodstream. Even nanogram quantities of circulating LPS activate Toll-like receptor 4 (TLR4) on macrophages and endothelial cells, triggering NF-κB and driving systemic low-grade inflammation. This mechanism, termed metabolic endotoxemia, was characterized by Patrice Cani and colleagues and explains part of why dietary patterns that damage the gut microbiome (ultra-processed foods, antibiotics, low fiber) accelerate inflammaging.

CMV Viral Burden and Immune Exhaustion

Cytomegalovirus (CMV) infects 50–85% of adults by age 70 and is never fully cleared by the immune system. CMV latency requires continuous immune surveillance, progressively filling the CD8+ T-cell repertoire with CMV-specific, terminally differentiated cells — a phenomenon called immune exhaustion or inflammaging inflation. CMV-seropositive older adults show higher IL-6, TNF-α, and hs-CRP than seronegative peers. CMV burden is considered a driver of immunosenescence and is associated with earlier mortality in elderly populations.

Dysfunctional Adipose Tissue Macrophages

Visceral adipose tissue is an endocrine organ — and in excess, an inflammatory organ. Adipocyte hypertrophy (fat cell enlargement) triggers macrophage recruitment into adipose tissue, where they adopt a pro-inflammatory M1 phenotype and secrete IL-6, TNF-α, MCP-1, and resistin continuously. This adipose-derived inflammation directly explains the relationship between central obesity, insulin resistance, and systemic inflammaging. Visceral fat, not subcutaneous fat, is the metabolically active inflammatory depot. Waist-to-height ratio above 0.5 correlates strongly with elevated inflammatory cytokines.

Advanced Glycation End Products (AGEs)

Advanced glycation end products form when glucose or fructose molecules non-enzymatically bind to proteins and lipids. AGEs accumulate with age, hyperglycemia, and dietary exposure to high-heat-processed foods (grilled, fried, ultra-processed). They bind to the receptor RAGE (receptor for advanced glycation end products), activating NF-κB and driving oxidative stress. AGE accumulation is measurable via skin autofluorescence and correlates with cardiovascular risk, retinopathy, and all-cause mortality independent of HbA1c.

Anti-Inflammatory Interventions: What the Evidence Actually Shows

The literature on anti-inflammatory interventions is vast, often contradictory, and heavily confounded by industry funding and surrogate endpoint studies. Below is a curated analysis of the highest-quality evidence for dietary, nutraceutical, and lifestyle interventions with demonstrated effects on inflammaging biomarkers.

Mediterranean Diet: The PREDIMED Evidence

The PREDIMED (Prevención con Dieta Mediterránea) trial remains the gold standard for dietary anti-inflammatory research. In this randomized controlled trial of 7,447 high-risk adults, a Mediterranean diet supplemented with extra-virgin olive oil or mixed nuts reduced major cardiovascular events by 30% compared to a low-fat control diet. Critically, the mechanism was partly anti-inflammatory: Mediterranean diet adherents showed a 40% reduction in hs-CRP, significantly reduced IL-6, and lower oxidized LDL. The key anti-inflammatory components are extra-virgin olive oil (oleocanthal inhibiting COX-1/COX-2), omega-3 from fatty fish, polyphenols from vegetables and legumes, and nuts providing tocopherols and resveratrol precursors.

Omega-3 Fatty Acids: EPA+DHA Mechanisms

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the biologically active marine omega-3 fatty acids that reduce inflammaging through multiple pathways. They compete with arachidonic acid for COX and LOX enzymes, reducing prostaglandin E2 and leukotriene B4 production. They also serve as precursors to specialized pro-resolving mediators (SPMs) — resolvins, protectins, and maresins — that actively terminate inflammatory signaling. Philip Calder's 2017 systematic review confirmed that EPA+DHA supplementation at doses above 2g/day significantly reduces TNF-α, IL-6, and IL-1β in clinical trials. The effect is dose-dependent: doses below 1g/day show inconsistent results.

The REDUCE-IT trial (Bhatt et al., 2018) showed that high-dose EPA (icosapentaenoic acid ethyl ester, 4g/day) reduced major cardiovascular events by 25% in patients already on statins, with anti-inflammatory biomarker reduction as a proposed mechanism beyond triglyceride lowering.

Polyphenols: Resveratrol, Quercetin, and Curcumin

Polyphenols exert anti-inflammaging effects primarily through NF-κB inhibition and SIRT1 activation.

• Curcumin is the most studied polyphenol anti-inflammatory. It inhibits NF-κB directly, suppresses COX-2 and iNOS, and reduces IL-6, TNF-α, and IL-1β in multiple meta-analyses. Its major limitation is bioavailability — standard curcumin is poorly absorbed. Piperine (from black pepper) increases bioavailability by 2,000% by inhibiting glucuronidation. Phospholipid complexes (Meriva, Phytosome) and nanoparticle formulations offer 6–30× improved absorption.
• Quercetin has both anti-inflammatory and senolytic properties. Combined with dasatinib, it has demonstrated senescent cell clearance in clinical trials (Kirkland/Mayo Clinic). Quercetin inhibits NLRP3 inflammasome activation and reduces IL-1β production independently.
• Resveratrol activates SIRT1, which deacetylates and inhibits NF-κB's p65 subunit. Its clinical translation has been complicated by poor bioavailability and rapid metabolism, but prodrug formulations and pterostilbene (a methylated resveratrol analog) show improved pharmacokinetics.

Caloric Restriction: The Most Consistent Evidence

Caloric restriction (CR) at 20–40% below ad libitum intake reduces IL-6, TNF-α, CRP, and insulin-like growth factor 1 (IGF-1) across nearly every animal model studied. The CALERIE trial — a 2-year randomized controlled trial of 25% caloric restriction in non-obese humans — showed significant reductions in CRP, TNF-α, and metabolic syndrome markers. CR reduces NLRP3 inflammasome activation, decreases adipose tissue macrophage infiltration, improves gut microbiome diversity, and activates AMPK and SIRT1 — the master negative regulators of NF-κB. Time-restricted eating (16:8 or 18:6 protocols) replicates some CR benefits without requiring chronic caloric deficit.

Exercise: The Hormesis Paradox

Exercise presents the clearest example of anti-inflammatory hormesis. Acute vigorous exercise triggers a sharp IL-6 spike (produced by contracting muscle as myokine) that lasts 4–8 hours post-exercise — this sounds inflammatory, but this acute IL-6 pulse drives subsequent IL-10 and IL-1Ra upregulation, producing a net anti-inflammatory effect. The exercise paradox is that exercise both raises and lowers IL-6: the acute spike is beneficial, while sedentary-baseline elevated IL-6 is pathological. Chronic regular exercise reduces resting IL-6, CRP, and TNF-α by 20–35% in meta-analyses. Zone 2 aerobic training (talking pace, 150+ min/week) produces the most consistent anti-inflammatory effect. High-intensity interval training (HIIT) adds benefits through NLRP3 suppression and mitophagy induction.

Centenarian Immunity: What Long-Lived Humans Teach Us About Inflammaging

The study of centenarians — individuals who survive to 100 and beyond — provides a natural experiment in successful inflammaging management. These individuals do not avoid inflammation; they appear to regulate it differently.

The IL-6 -174 G/C Polymorphism

A functional single nucleotide polymorphism in the promoter region of the IL-6 gene (rs1800795, -174 G/C) determines baseline IL-6 transcriptional activity. The C allele produces lower IL-6 in response to inflammatory stimuli. Multiple cohort studies of centenarians — including Franceschi's original Italian centenarian study — found the C allele enriched in long-lived individuals relative to younger controls. The CC genotype is associated with lower baseline IL-6, preserved cognitive function in aging, and reduced cardiovascular risk. This genetic architecture suggests that constitutional low IL-6 production may be a prerequisite for exceptional longevity — or that the selection pressure of longevity filters for individuals who can control inflammatory responses.

FOXO3: The Longevity Transcription Factor

FOXO3 (Forkhead box O3) is a transcription factor regulated by insulin/IGF-1 signaling that controls oxidative stress resistance, apoptosis, and inflammatory gene expression. The rs2802292 variant of FOXO3 is the most replicated genetic longevity association in human studies, independently validated in cohorts from Hawaii, Italy, Germany, France, Denmark, and Japan. FOXO3 inhibits NF-κB-driven inflammatory gene transcription, upregulates antioxidant genes (MnSOD, catalase), and promotes autophagy. Activation of FOXO3 by reduced insulin/IGF-1 signaling, SIRT1, or AMPK may be a common denominator explaining why caloric restriction, exercise, and metformin all extend healthspan.

Supercentenarian Lessons: High Inflammation Tolerance

An unexpected finding from supercentenarian studies (110+ years) is that these individuals do not always have low absolute inflammatory markers. Some show elevated IL-6 and CRP but appear resistant to the downstream consequences. This suggests that what matters for longevity is not just the level of inflammation but the anti-inflammatory resilience — the capacity of regulatory systems (T-regulatory cells, IL-10, resolvin production) to counterbalance pro-inflammatory signals. Supercentenarians also show preserved cytotoxic NK cell activity, suggesting immune surveillance against senescent and pre-cancerous cells remains intact while systemic inflammatory signaling is contained.

Evidence Table: Landmark Inflammaging Studies

The Anti-Inflammaging Protocol: 8 Evidence-Based Steps

The following protocol synthesizes the highest-quality evidence into a practical daily framework. Each step targets a distinct inflammaging mechanism, and they are synergistic — combining all eight produces greater effect than any single intervention.

• 1
  Measure your baseline inflammation panel

  Order hs-CRP, IL-6 (if available), fibrinogen, and fasting insulin. Add a CIMT (carotid intima-media thickness) scan if possible. You cannot optimize what you don't measure. Repeat every 3–6 months to assess intervention response.

• 2
  Adopt a Mediterranean-pattern diet as your foundation

  Extra-virgin olive oil as primary fat (30–50mL/day), 3+ servings of fatty fish per week, 7+ servings of vegetables daily, legumes 3×/week, eliminate ultra-processed foods and refined seed oils (linoleic acid excess promotes arachidonic acid pathway activity).

• 3
  Supplement high-dose omega-3 (EPA+DHA ≥2g/day)

  Target EPA+DHA combined above 2g/day from a triglyceride-form fish oil or algal oil. Check omega-3 index (target >8%) to confirm absorption. Take with the largest meal of the day to improve absorption by up to 50%.

• 4
  Add bioavailable curcumin with piperine

  500–1,000mg curcumin formulated with piperine (black pepper extract) or as a phospholipid complex. Take with food. Curcumin inhibits NF-κB directly and reduces IL-6 and CRP measurably within 8–12 weeks of consistent supplementation.

• 5
  Exercise 150+ min/week Zone 2 aerobic + 2× resistance training

  Zone 2 (conversational pace) cardio produces the most consistent reductions in resting IL-6 and CRP. Resistance training reduces visceral adipose tissue and SASP burden. Both are required — neither alone produces the full anti-inflammatory effect.

• 6
  Implement time-restricted eating (16:8 or 18:6)

  Compresses the eating window to 6–8 hours, allowing extended fasting periods that reduce NLRP3 activity, improve insulin sensitivity, and reduce AGE exposure. Targets the same mechanisms as caloric restriction without requiring chronic caloric deficit.

• 7
  Optimize gut microbiome diversity

  High-fiber diet (30+ plant species/week) feeds anti-inflammatory Bifidobacterium and Lactobacillus species that maintain gut barrier integrity and reduce LPS translocation. Fermented foods (kefir, kimchi, sauerkraut) have been shown in RCTs to reduce inflammatory markers and increase microbiome diversity within 10 weeks.

• 8
  Prioritize sleep quality and stress management

  Poor sleep (under 6 hours or fragmented sleep) elevates IL-6 and CRP measurably the following day. Chronic psychological stress activates NF-κB via glucocorticoid receptor dysregulation. 7–9 hours of sleep and mind-body practices (MBSR, yoga) reduce inflammatory biomarkers in RCTs.

Recommended Supplements for Inflammaging

The two supplements with the strongest and most consistent evidence for reducing inflammaging biomarkers are high-dose omega-3 and bioavailable curcumin. Below are vetted options based on third-party testing, formulation quality, and clinical dosing standards.

Related LongevityLab Research